Skip to content

FIVE ARROWS

FIVE ARROWS is a growth-equity, buyout, debt and other fund in the US and Europe writing $25M–$400M checks into Healthcare, data-and-software and technology-enabled-business-services.

Stages
growth-equity, buyout, debt, other
Sectors
Healthcare, data-and-software, technology-enabled-business-services
Check size
$25M–$400M
Invests in
US-wide, Europe
Actively investing
Yes
Founded
2008
Assets under management
> €34 billion

Thesis

Five Arrows, the alternative assets division of Rothschild & Co, is a global investment firm established in 2008, with a strong focus on private equity and credit markets across Europe and North America. The firm manages over €34 billion in AUM, deploying capital through various strategies including corporate private equity, fund investing, co-investments, and credit. Their investment thesis centers on mid-market opportunities, particularly in asset-light or service-oriented companies within the Data and Software, Healthcare, and Technology-Enabled Business Services sectors. They invest across growth equity and buyout stages, with specific ticket sizes varying by market segment: lower middle-market (€30M-€100M), middle-market (€100M-€300M, with co-investment capabilities exceeding €300M), and upper middle-market (over €400M). Their direct lending strategy targets European mid-market companies (€50M-€750M enterprise value) with investment sizes of €25M-€125M. The firm emphasizes a long-term, partnership-led approach, leveraging Rothschild & Co's network and expertise.

Common questions

Does FIVE ARROWS invest at the growth-equity stage?

Yes. FIVE ARROWS lists growth-equity, buyout, debt and other among the stages it invests in.

What check size does FIVE ARROWS write?

FIVE ARROWS writes $25M–$400M checks.

Where does FIVE ARROWS invest?

FIVE ARROWS invests in the US and Europe.